[October 10th, 2020 Qingdao] YAFO Life Science, along with our partners, has successfully organized ACCESS CHINA Autumn Event on September 25th at Shangri-La Hotel in Qingdao. We helped over 50 overseas companies to present about 140 assets in front of hundreds of big pharmaceutical companies in China.

On September 24th, the 15th China Pharma & Medtech BD Summit was held in Qingdao, Shandong. This forum gathered about 500 business representatives from major pharmaceutical companies in China including MNCs, as well as VCs and PEs.(Review the Forum speakers in the following pictures)

During this event, Mr. Sean Jiang, the Founder and CEO of YAFO Capital, gave a speech on China Biopharma Innovation and Out-Licensing Trends.

In addition, Mr. Fan Zheng, the Managing Director of YAFO Life Science, has received the “CHBD Global Transaction Award of the Year” at the 15th China Pharma & Medtech BD Summit. Fan has completed more than a dozen large cross-border pharmaceutical deals. In 2020, under the worldwide challenge of COVID-19, Fan jointly led the YAFO investment banking team and CHBD to launch the ACCESS CHINA virtual roadshow platform, which has successfully brought 115 innovative pharmaceutical companies from the United States, Europe, Japan and South Korea to China for online roadshows. ACCESS CHINA platform has greatly promoted the cooperation between overseas innovative pharmaceutical companies and China's pharmaceutical industry.

We would like to thank the following presenters who gave impressive presentations on our Autumn event. (The following names are in random order.)

James Harell, CCO of Cerecor

Steven Kim, BD Director of CrystalGenomics

Thomas Mehrling, CEO of TNT Medical

Ping Rawson, CFO of Dyadic International

Glenn Dourado, CBO of 4D Pharma

Yuta Lee, CEO of Accelerated Bio

Toru Kumagai, CEO of Medilabo RFP

Dr. Heinz Lubenau, CEO of VAXXIM

Ye Tian, CEO of Theravectys

Richard Ganz, Chairman of Sentien Biotech

Shyam Pattabiraman, CFO of Jubiliant LS

Maria Chen, BD Director of Immunwork

Francesc Mitjans, CSO of LYKERA BIOMED

Jeffrey Cleland, CEO of Ashvattha Therapeutics

Zhenghong Ling, Executive VP of Kanghong Yaoyuan

Marc Castelltort, CEO of Ninevah Therapeutics

Gonzague Issenmann, Co-founder of WOMED

Sanjeev Saxena, CEO of Onkos

Sham Nikam, CEO of ARTham Therapeutics

Daniel Katzman, CEO of Unleash Immuno Oncolytics

Peter Willinger, CFO of Apogenix AG

Miguel Forte, CEO of Bone Therapeutics

Vishal Doshi, CEO of AUM Oncology

Christian Pangratz, CEO of Sterna Biologicals

Claus Elsborg Olesen, CEO of Initiator Pharma

Yuhui, BD Manager of Carephar

Dr. Dong, Investment Director of Jiangxi Jemincare Group

Yan Yang, BD Manager of Bicazer Biotech

YAFO Upcoming Events - ACCESS CHINA WINTER EVENT (Jan. 2021, JPM)

This coming winter, YAFO will bring ACCESS CHINA-Winter Partnering Event virtually during the 2021 JPM conference. ACCESS CHINA will also offer 1x1 meeting system to presenting companies. Follow us on LinkedIn to join our future event:

https://www.linkedin.com/company/yafo-capital

About ACCESS CHINA: The most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. Access China creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.

ABOUT YAFO Life Science: The investment banking division of YAFO Capital with a focus on global biopharma licensing, financing, and M&A, representing leading healthcare clients from the U.S., Europe, Israel, and Asia. YAFO Life Science is dedicated to bringing global pharmaceutical and medical device products to China.